This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (February 2022) |
Jason C. Kovacic | |
---|---|
![]() Jason C. Kovacic | |
Born | |
Nationality | Australian, American |
Alma mater | University of New South Wales University of Melbourne |
Known for | Internationally recognised cardiologist and physician-scientist |
Scientific career | |
Fields | Clinical and interventional cardiology Vascular biology and pathology |
Institutions | Victor Chang Cardiac Research Institute University of New South Wales Icahn School of Medicine at Mount Sinai National Institutes of Health |
Website | Professor Jason Kovacic Jason C Kovacic |
Jason C. Kovacic (born 1968) is an Australian-born cardiologist and physician-scientist; the Robert Graham Chair and Professor of Medicine, University of New South Wales; Executive Director of the Victor Chang Cardiac Research Institute [1] in Sydney, Australia; and Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai, New York. [2]
Jason Kovacic graduated with a degree in Medicine from the University of Melbourne [3] in 1994. While undertaking his degree, Kovacic deferred his studies to compete in the 1986 Junior World Rowing Championships [4] and to take up a Rowing Scholarship at the Australian Institute of Sport (AIS) in Canberra. [5] While in Canberra, Kovacic completed a Bachelor of Medical Science degree in exercise physiology related to blood viscosity in elite rowers [6] at the AIS. Afterward, he resumed his Medicine studies in Melbourne, graduating in 1994. [3] Kovacic also rowed for state of Victoria with members of the Oarsome Foursome and won the 1994 Australian Men's Interstate Eight-Oared Rowing Championship - The King's Cup. [7]
Kovacic undertook a residency at Prince of Wales Hospital, [3] and cardiology specialty training at St. Vincent’s Hospital, Sydney. [8] As a cardiology trainee in early 2003, Kovacic was the doctor for Rolling Stones for some of their Licks World Tour Australian shows. [5] He completed his cardiology specialty training and became a Fellow of the Royal Australasian College of Physicians in 2003. [9]
Kovacic pursued a PhD at the Victor Chang Cardiac Research Institute focusing on the application of cell therapy to treat patients with refractory ischemic heart disease. [10] In 2007 he relocated to the US's National Heart, Lung and Blood Institute (NHLBI) at the National Institutes of Health (NIH) in Bethesda, Maryland [8] where he undertook a two year postdoctoral fellowship with the Director, Elizabeth Nabel. [11] In 2009 Kovacic moved to Mount Sinai Hospital in New York and after a further fellowship in interventional cardiology, [12] went on to become a faculty member [2] in 2010. Kovacic went on to become board certified in both internal medicine and cardiology with the American Board of Internal Medicine. [13]
As a physician-scientist, cardiologist and investigator at the Icahn School of Medicine at Mount Sinai. [2] Kovacic established a cardiovascular research laboratory with an interest in the cellular, molecular and genetic mechanisms underlying cardiovascular disease [14] His lab at Mount Sinai received its first NIH grant [14] in 2010.
Kovacic's scientific achievements include successful investigator-initiated clinical studies of cardiovascular progenitor cell therapy, [15] molecular characterization of a novel vascular progenitor cell population [11] unravelling the pathobiology of fibromuscular dysplasia and spontaneous coronary artery dissection, [15] numerous basic and translational studies on the biology and manifestations of atherosclerosis, [15] and studies regarding the role of endothelial to mesenchymal transition (EndMT) in adult vascular biology and disease. [16]
Kovacic also established a clinical practice as an interventional and clinical cardiologist. [2] [17] From 2015 to 2020, Kovacic was the Associate Director of the Interventional Structural Heart Disease Program at Mount Sinai Hospital. [18]
Kovacic became full Professor of Medicine (Cardiology) at Mount Sinai Hospital, [19] and in 2019 was the Director of Cardiovascular Translational Science and Acting Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai. [12]
In 2020 Kovacic became the Executive Director of the Victor Chang Cardiac Research Institute and the Robert Graham Chair and Professor of Cardiovascular Research at the University of New South Wales. [1] His cardiovascular research program spans Mount Sinai and the Victor Chang Cardiac Research Institute. He also works as a cardiologist at St. Vincent’s Hospital, Sydney [17]
Kovacic has given over 60 US and other international invited presentations and served on many US NIH committees and panels. He is Section Editor of the Journal of the American College of Cardiology. [24] and an Editorial Board Member at the journals Vascular Medicine [25] and Cardiovascular Research. He is also on the Board of Directors of the Australian Cardiovascular Alliance (ACvA) [9]
Mount Sinai Hospital, founded in 1852, is one of the oldest and largest teaching hospitals in the United States. It is located in East Harlem in the New York City borough of Manhattan, on the eastern border of Central Park stretching along Madison and Fifth Avenues, between East 98th Street and East 103rd Street. The entire Mount Sinai health system has over 7,400 physicians, as well as 3,919 beds, and delivers over 16,000 babies a year.
The Icahn School of Medicine at Mount Sinai, formerly the Mount Sinai School of Medicine, is a private medical school in New York City, New York, United States. The school is the academic teaching arm of the Mount Sinai Health System, which manages eight hospital campuses in the New York metropolitan area, including Mount Sinai Hospital and the New York Eye and Ear Infirmary.
The Victor Chang Cardiac Research Institute (VCCRI) is an Australian non-profit medical research facility that is dedicated to finding cures for cardiovascular disease. With headquarters located in Darlinghurst, New South Wales, the research hub is home to more than 20 research laboratories and the Victor Chang Cardiac Research Institute Innovation Centre. The institute's mission is "the relief of pain and suffering, and the promotion of well-being, through an understanding of the fundamental mechanisms of cardiovascular disease". Its key research is focused on the prevention and treatment of various heart diseases, including arrhythmia, cardiac arrest, cardiomyopathy, congenital heart disease, heart attack, heart failure, high cholesterol, obesity, spontaneous coronary artery dissection (SCAD) and stroke.
Melvyn Rubenfire is a cardiologist in the University of Michigan Health System, as well as a professor in the department of internal medicine. He is also director of the preventive cardiology department.
Valentín Fuster Carulla, 1st Marquess of Fuster is a Spanish cardiologist and aristocrat.
David H. Adams is an American cardiac surgeon and the Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery, Icahn School of Medicine at Mount Sinai Hospital in New York City. Dr. Adams is a recognized leader in the field of heart valve surgery and mitral valve reconstruction. As director of Mount Sinai Mitral Valve Repair Center, he has set national benchmarks with >99% degenerative mitral valve repair rates, while running one of the largest valve repair programs in the United States. Dr. Adams is the co-inventor of 2 mitral valve annuloplasty repair rings – the Carpentier-McCarthy-Adams IMR ETlogix Ring and the Carpentier-Edwards Physio II Annuloplasty Ring, and is a senior consultant with royalty agreements with Edwards Lifesciences. He is also the inventor of the Tri-Ad Adams Tricuspid Annuloplasty ring with a royalty agreement with Medtronic. He is a co-author with Professor Alain Carpentier of the benchmark textbook in mitral valve surgery Carpentier's Reconstructive Valve Surgery. He is also the National Co-Principal Investigator of the FDA pivotal trial of the Medtronic-CoreValve transcatheter aortic valve replacement device.
Sean Patrick Pinney is an American cardiologist and the Director of both the Advanced Heart Failure and Cardiac Transplant Program and the Pulmonary Hypertension Program at Mount Sinai Medical Center in New York City.
Mary Ann McLaughlin is an American cardiologist, the author of multiple book chapters and an associate professor at Mount Sinai Medical Center in New York City.
Annapoorna Kini is an American cardiologist. She is Professor of Cardiology and Interventional Director of Structural Heart Program at Mount Sinai School of Medicine in New York City.
Jonathan L. Halperin is an American cardiologist and the author of Bypass (ISBN 0-89586-509-2), among the most comprehensive works on the subject of coronary artery bypass surgery. In addition, he is the Robert and Harriet Heilbrunn Professor of Medicine at The Mount Sinai School of Medicine as well as Director of Clinical Cardiology in the Zena and Michael A. Wierner Cardiovascular Institute at The Mount Sinai Medical Center, both in New York City. Halperin was the principal cardiologist responsible for both the design and execution of the multi-center Stroke Prevention in Atrial Fibrillation (SPAF) clinical trials, funded by the National Institutes of Health, which helped develop antithrombotic strategies to prevent stroke, and he subsequently directed the SPORTIF clinical trials, which evaluated the first oral direct thrombin inhibitor for prevention of stroke in patients with atrial fibrillation.
Ron Waksman is a cardiologist. He is the Associate Director, Division of Cardiology, Washington Hospital Center (WHC) and professor of medicine (cardiology) at Georgetown University.
Ashok Seth is an Indian interventional cardiologist, credited with the performance of over 50,000 angiograms and 20,000 angioplasties, which has been included in the Limca Book of Records, a book for achievements and records from an Indian perspective. He is a Fellow of the Royal Colleges of Physicians of London, Edinburgh and Ireland and serves as the chief cardiologist, holding the chairs of the department of cardiovascular sciences and cardiology council at the Fortis Healthcare. Seth, a recipient of the Order of Isabella the Catholic, was honored by the Government of India with the fourth highest Indian civilian award of Padma Shri, in 2003, followed by Padma Bhushan, the third highest Indian civilian award, in 2015.
Donald S. Baim was a researcher and clinician in the field of interventional cardiology. Baim's primary research focused on coronary blood flow, catheter intervention in heart disease, and congestive heart failure. His work helped to shift the use of catheters from a purely diagnostic tool to a therapeutic tool. After receiving a medical degree from Yale and initial medical training, residency and a fellowship at Stanford University Medical Center, Baim spent the bulk of his career at Beth Israel Hospital and at the Brigham and Women's Hospital in Boston. In 1993, Baim founded the Beth Israel Hospital's Cardiovascular Data Analysis Center (CDAC) -- later to be named Harvard Clinical Research Institute (HCRI). Baim died of cancer in November 2009. In October 2016, HCRI changed its name to the Baim Institute for Clinical Research.
Charles Kaye Friedberg (1905–1972) was an American cardiologist, known for his medical textbook Diseases of the Heart, which was a standard reference in cardiology during the 1950s and 1960s.
Samin K. Sharma is an American philanthropist of Indian descent and an interventional cardiologist who co-founded the Eternal Heart Care Centre and Research Institute in Jaipur (EHCC). Sharma has served on New York State’s Cardiac Advisory Board since 2004. As of 2021, he is Senior Vice-President, Operations & Quality at The Mount Sinai Hospital in New York and runs the Dr. Samin K. Sharma Family Foundation Cardiac Catheterization Laboratory. As of 2018, he is Chairman Board of Trustees, Association of Indians in America (AIA). As of 2022, he has been an investigator on 86 grants and multi-center trials and authored 486 peer-reviewed articles that have been cited 21,734 times.
Richard Gorlin was an American cardiologist known for his contributions to the fields of valvular heart disease, coronary artery disease and cardiac catheterization, digitalis and vasodilators in congestive heart failure, and thrombolysis in myocardial infarctions. Along with his father, developed the Gorlin formula used to calculate valve areas in aortic valve stenosis and mitral valve stenosis.
Partho P. Sengupta is an Indian-American cardiologist. He is the Henry Rutgers Professor of Cardiology and Chief of the Division of Cardiovascular Disease & Hypertension at the Robert Wood Johnson Medical School (RWJMS) and the Chief of Cardiology, Robert Wood Johnson University Hospital (RWJUH) since July 1, 2021. Between 2019 and 2021, Dr. Sengupta was the Abnash C. Jain Chair & Professor of Cardiology at West Virginia University School of Medicine and the Chief of Division of Cardiology, Chair of Cardiovascular Innovation and Director of Cardiac Imaging at West Virginia University Heart and Vascular Institute.
Robert Michael Graham AO, FAA, FAHMS is an Australian-born clinician-scientist. He is the Des Renford Professor of Medicine at University of New South Wales and the Head of the Molecular Cardiology and Biophysics Division at Victor Chang Cardiac Research Institute.
Roxana Mehran is an Iranian-American cardiologist and Mount Sinai Endowed Professor of Medicine at the Icahn School of Medicine at Mount Sinai. She is known for her work in interventional cardiology.
Ronald P. Karlsberg is an American academic and cardiologist. He is a clinical professor of medicine at the Cedars-Sinai Medical Center and the David Geffen School of Medicine at UCLA, specializing in clinical, preventive, and interventional cardiology.